🚨 Just published! 🚨
📄 Real-world outcomes following dual antiplatelet therapy in mild-to-moderate ischemic stroke with anterior versus posterior circulation infarct: a READAPT study propensity matched analysis
https://t.co/afAonFsoDb
🎉 Congratulations to @fededs00, neurologist and PhD candidate at @univaq, for receiving the @ESOstroke Young Investigator Award! 👏🏻👏🏻👏🏻
A well-deserved recognition!
Kudos to Raffaele Ornello, Matteo Foschi and Eleonora De Matteis, key members of the project team. So proud! 💪🏻🧠
One recurring question I often get during lectures on migraine, stroke, and PFO is about the use of antithrombotic therapy. To address this, we conducted a systematic review. Curious about the findings? Read the full article below.
Just published!📜📢
We are pleased to present our systematic review about the current evidence on antithrombotic drugs in migraine prevention and potential future applications.
https://t.co/h8aELz1ur6
@mattfos89@MicheleRomoli@ChiaraRosx@Simona_Sacco_@RaffaeleOrnello
#STROKE: The READAPT study shows that women with non-cardioembolic mild-to-moderate stroke or high-risk TIA treated with DAPT may have lower short-term risk of recurrent ischemic events than men. #AHAJournals#GoRedForWomen@GoRedForWomen https://t.co/eupd48kFt3